By Amie T. Camara

The news about AstraZeneca’s drug came on the same day that the company and others pledged to thoroughly vet any vaccine.

Afrinity Production unveil to you the News about pharmaceutical company AstraZeneca which just halted global trials of its coronavirus vaccine on Tuesday because of a serious and unexpected adverse reaction in a participant, the company said.

The trial’s halt, which was first reported by Stat News, will allow the British-Swedish company to conduct a safety review. How long the hold will last is unclear.

In a statement, the company described the halt as a “routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.”

The news of AstraZeneca pausing its trial came the same day the company and eight other drugmakers made a joint pledge to “stand with science” on coronavirus vaccines, reaffirming that they would not move forward with such products before thoroughly vetting them for safety and efficacy.

Source___Reuters_World News